RESUMO
With the increase in the aging of the global population, the prevalence of cataract has increased gradually, and cataract has become a significant cause of blindness and visual impairment in China and even in the whole world.In recent years, artificial intelligence (AI) technology has developed rapidly, and has been applied widely in medical fields, especially in ophthalmology.AI is expected to become a vital method to alleviate the lack of medical resources, improve the efficiency of diagnosis and treatment and reduce medical costs.For cataract, AI is mainly applied in cataract screening and diagnosis, preoperative evaluation, the calculation of intraocular lens power and the analysis of cataract surgery procedure.In this article, the researches on the applications of AI technology in the diagnosis and classification of cataract based on the slit-lamp/fundus photograph, ultrasound image, cataract surgery video and health record data, the grading of opacity, the calculation of intraocular lens power as well as the recognization of cataract surgery and the management of cataract patients at home and abroad were summarized and reviewed in order to provide more references for the application and promotion of AI in ophthalmology.
RESUMO
Objective:To evaluate the long-term health-related quality of life (QOL) in pediatric patients with acute leukemia after hematopoietic stem cell transplantation (HSCT) and to analyze potential influence factors.Methods:Patients with acute leukemia aging 8-18 years who received HSCT in the Hematology Oncology Center of Beijing Children′s Hospital from June 2009 to June 2012 with more than 80 months survival postoperatively were recruited.All of them were subjected to a short-term QOL survey in 2013.PedsQL? Transplantation Module 3.0 in Chinese mandarin version was completed.QOL data and influence factors were analyzed.Results:Forty-one patients completed the questionnaires, involving 32 males and 9 females with the mean age of(14.29±2.72) years.The mean scores of overall long-term QOL after HSCT were above 75 (total scores: 100), which was above the average.The age, disease status before transplantation, donor sources, post-transplant complications and the parental education level were the influential factors for the long-term QOL in pediatric patients with acute leukemia at post-HSCT, which could affect a certain dimension in QOL.Conclusions:The overall long-term QOL of pediatric patients with acute leukemia who survived for more than 80 months at post-HSCT is acceptable, which is significantly better than the short-term QOL after 4 months of HSCT.The age, disease status before transplantation, donor sources, post-transplant complications and the education level of parents could affect a certain dimension of QOL.